TD Cowen Reiterates Buy Rating on AstraZeneca (AZN)

May 22, 2024 11:25 AM EDT Send to a Friend
TD Cowen analyst Steve Scala reiterated a Buy rating and $86.00 price target on AstraZeneca (NASDAQ: AZN).The analyst commented, "Yesterday's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login